Skip to main content

Peer Review reports

From: Novel quinazolines bearing 1,3,4-thiadiazole-aryl urea derivative as anticancer agents: design, synthesis, molecular docking, DFT and bioactivity evaluations

Original Submission
24 Jul 2023 Submitted Original manuscript
22 Aug 2023 Author responded Author comments - Alireza Foroumadi
Resubmission - Version 2
22 Aug 2023 Submitted Manuscript version 2
30 Aug 2023 Reviewed Reviewer Report
15 Sep 2023 Reviewed Reviewer Report
12 Dec 2023 Author responded Author comments - Alireza Foroumadi
Resubmission - Version 3
12 Dec 2023 Submitted Manuscript version 3
14 Dec 2023 Author responded Author comments - Alireza Foroumadi
Resubmission - Version 4
14 Dec 2023 Submitted Manuscript version 4
20 Dec 2023 Reviewed Reviewer Report
26 Dec 2023 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
9 Jan 2024 Editorially accepted
12 Feb 2024 Article published 10.1186/s13065-024-01119-0

You can find further information about peer review here.

Back to article page